Member News

PRESS RELEASE: Pat Garcia-Gonzalez Receives Outstanding Contribution to Cancer Control Award by UICC

The Max Foundation CEO recognized for unwavering dedication to global, widespread health equity

The Max Foundation, a global non-profit organization that aims to make lifesaving cancer treatment universal, is thrilled to announce its CEO and co-founder Pat Garcia-Gonzalez won the Union for International Cancer Control’s (UICC) Outstanding Contribution to Cancer Control Award in the Civil Society category. Given to leaders who drive innovation to advance cancer control in an equitable manner, this award celebrates a significant achievement in Pat’s relentless effort to expand access to cancer treatment for thousands of people worldwide. Read More “PRESS RELEASE: Pat Garcia-Gonzalez Receives Outstanding Contribution to Cancer Control Award by UICC”

Pat Garcia-Gonzalez Joins Shortlist of Nominees for UICC’s Outstanding Contribution to Cancer Control Award

Pat joins Paul Farmer, President Joe Biden, and other world leaders in “Driving innovation to advance cancer control equitably” 

We are pleased to announce The Max Foundation CEO and co-founder, Pat Garcia-Gonzalez, has been nominated as one of three finalists for the Outstanding Contribution to Cancer Control Award, by UICC. We are honored to see The Max Foundation’s efforts recognized by the UICC.

Pat Garcia-Gonzalez shared her gratitude, saying, “This nomination means the world to me and to all whose voices we represent. At The Max Foundation we believe that all people should be able to access the treatment Read More “Pat Garcia-Gonzalez Joins Shortlist of Nominees for UICC’s Outstanding Contribution to Cancer Control Award”

PRESS RELEASE: Oxfam Reaction to Johnson & Johnson Vaccine Submission for FDA Approval

In response to Johnson & Johnson (JNJ)’s submission of their COVID-19 vaccine for emergency approval from the US Food & Drug Administration, Niko Lusiani, Senior Advisor with Oxfam America, made the following statement:

“Scientists have yet again delivered hope in the war against the coronavirus. As a single-dose and lower-cost vaccine, the JNJ vaccine could deliver the necessary boost the world needs to save lives and rebuild our economy.

“Now it’s time for executives and policy makers to deliver a people’s vaccine that is mass produced around the world to ensure access to the greatest number of people in the Read More “PRESS RELEASE: Oxfam Reaction to Johnson & Johnson Vaccine Submission for FDA Approval”